×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LMAT – lemaitre vascular, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LMAT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/16
11:15 am
lmat
Surgical Equipment & Consumables - Specialty Stocks Q4 Earnings: LeMaitre (NASDAQ:LMAT) Firing on All Cylinders [Yahoo! Finance]
Low
Report
Surgical Equipment & Consumables - Specialty Stocks Q4 Earnings: LeMaitre (NASDAQ:LMAT) Firing on All Cylinders [Yahoo! Finance]
4/15
06:58 am
lmat
LeMaitre Vascular (LMAT) was upgraded by Zacks Research from "hold" to "strong-buy".
Low
Report
LeMaitre Vascular (LMAT) was upgraded by Zacks Research from "hold" to "strong-buy".
4/14
04:54 pm
lmat
LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
Low
Report
LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
4/7
02:39 pm
lmat
LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
Low
Report
LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
4/2
07:32 am
lmat
LeMaitre Vascular (LMAT) was upgraded by Freedom Capital to "hold".
Low
Report
LeMaitre Vascular (LMAT) was upgraded by Freedom Capital to "hold".
3/29
11:23 pm
lmat
Why The LeMaitre Vascular (LMAT) Story Is Evolving As Targets Cluster Around US$111 [Yahoo! Finance]
Low
Report
Why The LeMaitre Vascular (LMAT) Story Is Evolving As Targets Cluster Around US$111 [Yahoo! Finance]
3/29
07:38 pm
lmat
Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now? [Yahoo! Finance]
Low
Report
Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now? [Yahoo! Finance]
3/27
09:03 pm
lmat
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know [Yahoo! Finance]
Low
Report
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/14
07:36 am
lmat
Form DEFA14A LEMAITRE VASCULAR INC
Low
Report
Form DEFA14A LEMAITRE VASCULAR INC
4/14
07:34 am
lmat
Form DEF 14A LEMAITRE VASCULAR INC For: Apr 13
Low
Report
Form DEF 14A LEMAITRE VASCULAR INC For: Apr 13
4/14
06:45 am
lmat
Form 8-K LEMAITRE VASCULAR INC For: Apr 08
Low
Report
Form 8-K LEMAITRE VASCULAR INC For: Apr 08
4/14
06:30 am
lmat
Form ARS LEMAITRE VASCULAR INC For: Dec 31
Low
Report
Form ARS LEMAITRE VASCULAR INC For: Dec 31
3/30
06:10 pm
lmat
Form 4 LEMAITRE VASCULAR INC For: Mar 26 Filed by: SHADAN MARTHA
Low
Report
Form 4 LEMAITRE VASCULAR INC For: Mar 26 Filed by: SHADAN MARTHA
3/30
06:03 pm
lmat
Form 4 LEMAITRE VASCULAR INC For: Mar 26 Filed by: O'Connor John James
Low
Report
Form 4 LEMAITRE VASCULAR INC For: Mar 26 Filed by: O'Connor John James
3/30
06:03 pm
lmat
Form 4 LEMAITRE VASCULAR INC For: Mar 26 Filed by: Ross Bridget A
Low
Report
Form 4 LEMAITRE VASCULAR INC For: Mar 26 Filed by: Ross Bridget A
3/30
06:02 pm
lmat
Form 4 LEMAITRE VASCULAR INC For: Mar 26 Filed by: Roush John A
Low
Report
Form 4 LEMAITRE VASCULAR INC For: Mar 26 Filed by: Roush John A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Form 4 LEMAITRE VASCULAR INC For: Mar 19 Filed by: LeMaitre George W
9.6%
4/6 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target lowered by analysts at Lake Street Capital from $40.00 to $28.00. They now have a "buy" rating on the stock. 6.1%
4/13 LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results 3.8%
7/20 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.6%
10/13 LeMaitre Vascular Acquires Biologic Patch Business from Admedus 3.4%
9/9 Form 4 LEMAITRE VASCULAR INC For: Sep 05 Filed by: LeMaitre George W 3.2%
10/22 Form 4 LEMAITRE VASCULAR INC For: Oct 18 Filed by: Roberts David B 3.1%
7/22 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 3.0%
7/17 Form 4 LEMAITRE VASCULAR INC For: Jul 16 Filed by: O'Connor John James 2.8%
2/11 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $33.00 price target on the stock. 2.8%
4/6 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target lowered by analysts at Lake Street Capital from $40.00 to $28.00. They now have a "buy" rating on the stock. 6.1%
4/13 LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results 3.8%
7/20 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.6%
10/13 LeMaitre Vascular Acquires Biologic Patch Business from Admedus 3.4%
9/9 Form 4 LEMAITRE VASCULAR INC For: Sep 05 Filed by: LeMaitre George W 3.2%
10/22 Form 4 LEMAITRE VASCULAR INC For: Oct 18 Filed by: Roberts David B 3.1%
7/22 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 3.0%
7/17 Form 4 LEMAITRE VASCULAR INC For: Jul 16 Filed by: O'Connor John James 2.8%
2/11 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $33.00 price target on the stock. 2.8%
TOP News Decliners
2/6
Form 8-K LEMAITRE VASCULAR INC For: Feb 06
-19.5%
3/12 Form 10-K LEMAITRE VASCULAR INC For: Dec 31 -18.1%
3/16 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $38.00 price target on the stock. -9.7%
7/25 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $32.00 to $37.00. They now have an "outperform" rating on the stock. -8.7%
4/30 Q1/2020 3/31/2020 EPS 0.160 ZacksConsensus 0.160 ActVsEst 0.000 - In-Line -7.4%
4/30 LeMaitre Vascular Inc (NASDAQ: LMAT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.2%
4/17 Form 8-K LEMAITRE VASCULAR INC For: Apr 13 -5.6%
4/21 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.5%
10/23 Q3/2019 9/30/2019 EPS 0.250 ZacksConsensus 0.210 ActVsEst 0.040 - Beat -4.5%
11/5 Form 4 LEMAITRE VASCULAR INC For: Nov 01 Filed by: LeMaitre George W -4.2%
3/12 Form 10-K LEMAITRE VASCULAR INC For: Dec 31 -18.1%
3/16 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $38.00 price target on the stock. -9.7%
7/25 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $32.00 to $37.00. They now have an "outperform" rating on the stock. -8.7%
4/30 Q1/2020 3/31/2020 EPS 0.160 ZacksConsensus 0.160 ActVsEst 0.000 - In-Line -7.4%
4/30 LeMaitre Vascular Inc (NASDAQ: LMAT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.2%
4/17 Form 8-K LEMAITRE VASCULAR INC For: Apr 13 -5.6%
4/21 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.5%
10/23 Q3/2019 9/30/2019 EPS 0.250 ZacksConsensus 0.210 ActVsEst 0.040 - Beat -4.5%
11/5 Form 4 LEMAITRE VASCULAR INC For: Nov 01 Filed by: LeMaitre George W -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: